| Induction therapy with monoclonal antibodies specific for cd80 and cd86 delays the onset of acute renal allograft rejection in non-human primates1 AD Kirk, DK Tadaki, A Celniker, DS Batty, JD Berning, JO Colonna, ... Transplantation 72 (3), 377-384, 2001 | 177 | 2001 |
| Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors AD Kirk, A Guasch, H Xu, J Cheeseman, SI Mead, A Ghali, AK Mehta, ... American Journal of Transplantation 14 (5), 1142-1151, 2014 | 129 | 2014 |
| TREATMENT WITH THE HUMANIZED CD154-SPECIFIC MONOCLONAL ANTIBODY, hu5C8, PREVENTS ACUTE REJECTION OF PRIMARY SKIN ALLOGRAFTS IN NONHUMAN PRIMATES1 EA Elster, H Xu, DK Tadaki, S Montgomery, LC Burkly, JD Berning, ... Transplantation 72 (9), 1473-1478, 2001 | 120 | 2001 |
| Platelet-derived or soluble CD154 induces vascularized allograft rejection independent of cell-bound CD154 H Xu, X Zhang, RB Mannon, AD Kirk The Journal of clinical investigation 116 (3), 769-774, 2006 | 112 | 2006 |
| IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates EH Preston, H Xu, KK Dhanireddy, JP Pearl, FV Leopardi, MF Starost, ... American Journal of Transplantation 5 (5), 1032-1041, 2005 | 105 | 2005 |
| The role of CD154 in organ transplant rejection and acceptance AD Kirk, PJ Blair, DK Tadaki, H Xu, DM Harlan Philosophical Transactions of the Royal Society of London. Series B …, 2001 | 95 | 2001 |
| Composite tissue allotransplantation: development of a preclinical model in nonhuman primates LC Cendales, H Xu, J Bacher, MA Eckhaus, DE Kleiner, AD Kirk Transplantation 80 (10), 1447-1454, 2005 | 86 | 2005 |
| Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation H Xu, SP Montgomery, EH Preston, DK Tadaki, DA Hale, DM Harlan, ... The Journal of Immunology 170 (5), 2776-2782, 2003 | 80 | 2003 |
| Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation SP Montgomery, H Xu, DK Tadaki, A Celniker, LC Burkly, JD Berning, ... Transplantation 74 (10), 1365-1369, 2002 | 74 | 2002 |
| The allo-and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation H Xu, SD Perez, J Cheeseman, AK Mehta, AD Kirk American journal of transplantation 14 (2), 319-332, 2014 | 71 | 2014 |
| Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site B Hirshberg, S Montgomery, MG Wysoki, H Xu, D Tadaki, J Lee, K Hines, ... Diabetes 51 (7), 2135-2140, 2002 | 62 | 2002 |
| Circulating mitochondria in organ donors promote allograft rejection L Lin, HE Xu, M Bishawi, FF Feng, K Samy, G Truskey, AS Barbas, ... American Journal of Transplantation 19 (7), 1917-1929, 2019 | 52 | 2019 |
| Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in … H Xu, KK Dhanireddy, AD Kirk The Journal of Immunology 176 (2), 750-761, 2006 | 49 | 2006 |
| Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates H Xu, DK Tadaki, EA Elster, LC Burkly, JD Berning, F Cruzata, ... Transplantation 74 (7), 940-943, 2002 | 47 | 2002 |
| Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model SP Montgomery, SR Mog, H Xu, DK Tadaki, B Hirshberg, JD Berning, ... American Journal of Transplantation 2 (4), 381-385, 2002 | 35 | 2002 |
| Human platelets activate porcine endothelial cells through a CD154-dependent pathway12 H Xu, F Arnaud, DK Tadaki, LC Burkly, DM Harlan, AD Kirk Transplantation 72 (11), 1858-1861, 2001 | 33 | 2001 |
| Upregulation of molecules associated with T-regulatory function by thymoglobulin pretreatment of human CD4+ cells Z Liu, Y Fang, X Wang, P Wang, P Yun, H Xu Transplantation 86 (10), 1419-1426, 2008 | 31 | 2008 |
| Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up R Schmitz, ZW Fitch, H Xu, A Ghali, AK Mehta, A Guasch, AD Kirk American Journal of Transplantation 20 (12), 3609-3619, 2020 | 30 | 2020 |
| Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model H Xu, E Elster, D Batty, J Berning, L Burkly, R Kampen, S Swanson, ... Transplantation proceedings 1 (33), 223-224, 2001 | 27 | 2001 |
| Primate skin allotransplantation with anti-CD154 monotherapy. EA Elster, H Xu, DK Tadaki, LC Burkly, JD Berning, RE Baumgartner, ... Transplantation proceedings 33 (1-2), 675-676, 2001 | 26 | 2001 |
